SUDA Pharmaceuticals Proposed Share Consolidation for Effective Capital Structure

NEWS Oct 17, 2019

Based in the United States and Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a leading drug delivery company of the world engaged in the reformulation of existing medications and delivery of drugs via the oral mucosa. To reformulate the existing ...

SUDA Prospers Via Drug Delivery Partnerships: A Quick Review of Deals Transacted for ZolpiMist<sup>TM</sup>

NEWS Oct 09, 2019

Oro-mucosal drug delivery giant, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the pharmaceutical development of drug delivery technology. To increase bioavailability, the company is reformulating the existing drugs into oral sprays. The comp...

Insight into Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceutical’s FY19 Annual Report

NEWS Sep 27, 2019

Australian-headquartered global pharmaceutical leader, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the reformulation of existing drugs and provision of medication via the oral mucosa. The company uses its exclusive OroMist® technology to cr...

SUDA Pharmaceuticals Progressing Well in 2019 with Significant Regulatory and Patent Approvals

NEWS Sep 20, 2019

Australia’s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) develops low-risk, easy-to-use oral sprays using its OroMist® technology to reformulate existing medications. The company’s oral-delivery technology is not onl...

SUDA’s OroMist® Technology Revamping Pharmaceutical Industry

NEWS Sep 12, 2019

Australian headquartered pharmaceutical giant, SUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery leader, engaged in the reformulation of existing medications into oral sprays. The company aims to boost the lifestyle and health of th...

Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

NEWS Sep 04, 2019

Drugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking medicine, because only about 25% of the drug reaches where it should. Several factors including food affect, enzymatic degradation, drug metabolism, an...

SUDA Pharmaceuticals Reformulating Billion-Dollar Drugs for Oral Delivery

NEWS Aug 30, 2019

Australia’s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) produces reliable oral sprays by using its proprietary OroMist® technology to redevelop the ex-blockbuster drugs. SUDA’s low-risk oral sprays possess the abili...

SUDA Makes Speedy Progress with its Robust Product Pipeline

Suda Pharmaceuticals Ltd (ASX: SUD) Aug 21, 2019

SUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the lifestyle and health of the global community by offering innovative and high-quality oro-mucosal spray pharmaceutical products to aid in the treatment of ...

SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide Project

NEWS Aug 14, 2019

SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery company headquartered in Perth, focusses on developing low-risk oral sprays using its proprietary OroMist® oro-mucosal technology to reformulate the existing medications. The OroMist® ...